These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 2973508)

  • 21. Changes in the host natural killer cell population in mice during tumor development. 1. Kinetics and in vivo significance.
    Lala PK; Santer V; Libenson H; Parhar RS
    Cell Immunol; 1985 Jul; 93(2):250-64. PubMed ID: 4005957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indomethacin modulation of adriamycin-induced effects on multiple cytolytic effector functions.
    Maccubbin DL; Cohen SA; Ehrke MJ
    Cancer Immunol Immunother; 1990; 31(6):373-80. PubMed ID: 2386983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice.
    Young MR; Newby M
    J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eradication of spontaneous and experimental adenocarcinoma metastases with chronic indomethacin and intermittent IL-2 therapy.
    Lala PK; Parhar RS
    Int J Cancer; 1993 Jun; 54(4):677-84. PubMed ID: 8514459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cancer immunotherapy with indomethacin and interleukin-2 on murine hemopoietic stem cells.
    Saarloos MN; Khoo NK; Lala PK
    Cancer Res; 1992 Dec; 52(23):6452-62. PubMed ID: 1423293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E2 from macrophages of murine splenocyte cultures inhibits the generation of lymphokine-activated killer cell activity.
    Ohnishi H; Lin TH; Nakajima I; Chu TM
    Tumour Biol; 1991; 12(2):99-110. PubMed ID: 2028183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
    Dussault I; Miller SC
    Nat Immun; 1993; 12(2):66-78. PubMed ID: 8318817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of murine lymphokine-activated killer (LAK) cell activity by adherent cells.
    Longley RE; Stewart D; Roe KG; Good RA
    Cell Immunol; 1989 Jul; 121(2):225-36. PubMed ID: 2786756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PGE2 receptors on murine splenic lymphocytes: effects of tumor bearing.
    Elkashab M; Lala P
    Immunol Lett; 1991 Sep; 30(1):7-15. PubMed ID: 1660031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of activated killer cells in tumor-bearing hosts.
    Ting CC; Hargrove ME; Stephany D
    Int J Cancer; 1987 Feb; 39(2):232-9. PubMed ID: 3100459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of in vitro prostaglandin E2 production by mouse fibrosarcoma cells after co-culture with various anti-tumour effector cells.
    Okada F; Hosokawa M; Hasegawa J; Kuramitsu Y; Nakai K; Yuan L; Lao H; Kobayashi H; Takeichi N
    Br J Cancer; 1994 Aug; 70(2):233-8. PubMed ID: 8054271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of lymphocyte alloreactivity by early gestational human decidua. II. Characterization of the suppressor mechanisms.
    Lala PK; Kennedy TG; Parhar RS
    Cell Immunol; 1988 Oct; 116(2):411-22. PubMed ID: 3263215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of macrophages on interleukin-2 (IL-2)- and IL-4-induced murine lymphokine-activated killer activity.
    Tunru IS; Suzuki H; Yano S
    Int J Cancer; 1991 Jun; 48(4):568-73. PubMed ID: 2045201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations of rat natural killer (NK) cell cytotoxicity and cytokine production by 3-methylcholanthrene (3-MC).
    Talcott PA; Exon JH; Mather GG; Koller LD
    Int J Immunopharmacol; 1990; 12(8):917-26. PubMed ID: 2292469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PGE2, but not TGF beta 2, in rabbit blastocoelic fluid regulates the cytotoxic activities of NK and LAK cells.
    Bergeron D; Ouellette MJ; Lambert RD
    J Reprod Immunol; 1997 Jul; 33(3):203-19. PubMed ID: 9255724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The in vitro antitumor effectiveness of murine lymphokine-activated killer (LAK) cells induced by recombinant IL-2].
    Okamoto Y; Shimizu K; Miyao Y; Ushio Y; Matsui Y; Hayakawa T; Tsuda N; Mogami H
    No To Shinkei; 1986 Mar; 38(3):233-7. PubMed ID: 3486667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-gamma.
    Alleva DG; Burger CJ; Elgert KD
    Scand J Immunol; 1994 Jan; 39(1):31-8. PubMed ID: 7904773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin E2 production by Mac-2+ macrophages: tumor-induced population shift.
    Malick AP; Elgert KD; Garner RE; Adkinson NF
    J Leukoc Biol; 1987 Dec; 42(6):673-81. PubMed ID: 2960767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.